Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/06/2003CA2465676A1 Compositions and techniques for localized therapy of restenosis
03/06/2003CA2459974A1 Emu-based formulations for wound treatment related application information
03/06/2003CA2459183A1 Amplified oncogenes and their involvement in cancer
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458855A1 Composition for treating parkinson's disease containing a cb1 receptor antagonist and a product activating dopaminergic neurotransmission in the brain
03/06/2003CA2458852A1 Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
03/06/2003CA2458782A1 Compositions and methods for treating subjects with hyperglycemia
03/06/2003CA2458622A1 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458561A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003CA2458506A1 Wild-type ras as a cancer therapeutic agent
03/06/2003CA2458477A1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
03/06/2003CA2458476A1 Photoreactive compounds and compositions
03/06/2003CA2458443A1 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003CA2458408A1 Mutagenic nucleoside analogs for the treatment of viral disease
03/06/2003CA2458394A1 Lipophilic drug compositions
03/06/2003CA2458381A1 Transmembrane protein differentially expressed in cancer
03/06/2003CA2458375A1 Substituted-heteroaryl-7-aza¬2.2.1|bicycloheptanes for the treatment of disease
03/06/2003CA2458344A1 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
03/06/2003CA2458230A1 Method and composition for treatment of ocular hypertension and glaucoma
03/06/2003CA2458226A1 Improved nitroreductase enzymes
03/06/2003CA2458219A1 Oral rinse for treatment or prevention of bacterial and fungal infection
03/06/2003CA2458217A1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
03/06/2003CA2458135A1 Single dose azithromycin for treating respiratory infections
03/06/2003CA2458132A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture
03/06/2003CA2458131A1 Jnk activation inhibitor
03/06/2003CA2458129A1 The use of anthroquinones in the treatment of kidney disease
03/06/2003CA2458121A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/06/2003CA2458040A1 Antiviral protease inhibitors
03/06/2003CA2458015A1 Analgetic pyrroline derivatives
03/06/2003CA2458011A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
03/06/2003CA2457979A1 A delivery system
03/06/2003CA2457976A1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
03/06/2003CA2457974A1 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
03/06/2003CA2457955A1 Method for treating bronchial constriction and bronchospasm
03/06/2003CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003CA2457846A1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003CA2457838A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/06/2003CA2457794A1 Novel synthetic ganglioside derivatives and compositions thereof
03/06/2003CA2457676A1 Chemotherapeutic agents
03/06/2003CA2457590A1 Method and apparatus for acne treatment
03/06/2003CA2457532A1 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003CA2457488A1 Antimicrobial agent
03/06/2003CA2457341A1 A new extended release oral dosage form
03/06/2003CA2457339A1 A new extended release oral dosage form
03/06/2003CA2457196A1 Compositions containing itraconazole and their preparation methods
03/06/2003CA2457118A1 Targeted bisplatinum polyamines as pro-drugs: selective release of platinum
03/06/2003CA2456828A1 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003CA2456480A1 A combination of quetiapine and zolmitriptan
03/06/2003CA2456420A1 Novel cyclohexyl sulphones
03/06/2003CA2456350A1 Novel imidazopyridine compounds with therapeutic effect
03/06/2003CA2456349A1 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
03/06/2003CA2456348A1 Platinum complexes and their uses in therapy
03/06/2003CA2456280A1 Cyclopropyl and cyclobutyl epothilone analogs
03/06/2003CA2456269A1 Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
03/06/2003CA2455773A1 Substituted-aryl 7-aza¬2.2.1|bicycloheptanes for the treatment of disease
03/06/2003CA2455504A1 Anti-bacterial agents based upon oxoanion binding
03/06/2003CA2455497A1 Amidine derivatives for treating amyloidosis
03/06/2003CA2455311A1 Rapamycin dialdehydes
03/06/2003CA2455308A1 Rapamycin 29-enols
03/06/2003CA2451740A1 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
03/06/2003CA2449515A1 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
03/06/2003CA2430267A1 Hydrazinopeptoids and their uses for treating cancers
03/05/2003EP1288227A1 Coactivator of nuclear receptors
03/05/2003EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series
03/05/2003EP1288214A1 Paroxetine methanesulfonate
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1288203A1 Cyclic nitrones and pharmaceutical compositions containing them
03/05/2003EP1288202A1 N-acyltetrahydroisoquinoline derivatives
03/05/2003EP1287854A1 Anti-cancer combinations of DMXAA and paclitaxel or docetaxel
03/05/2003EP1287830A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
03/05/2003EP1287827A1 Immunopotentiator
03/05/2003EP1287826A1 A crystalline form of the free base of Amlodipine
03/05/2003EP1287825A1 Blends comprising a substituted fatty acid or a derivative thereof
03/05/2003EP1287822A2 Mesalazine controlled release oral pharmaceutical compositions
03/05/2003EP1287821A1 Multiparticulate formulations of atorvastatin calcium having a modulated rate of drug release
03/05/2003EP1287820A1 Aerosol compositions
03/05/2003EP1287817A1 Method of treating uterine leiomyomas and intravaginal drug delivery vehicle for use in such method
03/05/2003EP1287815A1 Use of a sphingoid base for inhibiting ceramidase activity
03/05/2003EP1287362A2 Compositions and methods for modulating tumor specific expression
03/05/2003EP1287355A2 Methods and compounds for influencing $g(b)3 integrin-dependent intracellular processes
03/05/2003EP1287349A2 Method and apparatus for monitoring anti-platelet agents
03/05/2003EP1287137A2 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287030A1 Insulin regulated substance (irs-2) induced by pioglitazone, assay and use thereof
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1287011A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
03/05/2003EP1287006A1 Antitumoral compounds
03/05/2003EP1287005A2 Benzoic acid esters having antiplasmid effect
03/05/2003EP1287003A1 Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
03/05/2003EP1287002A1 Crf receptor antagonists
03/05/2003EP1287001A1 Thiophene derivatives useful as anticancer agents
03/05/2003EP1286999A1 PYRANO[2,3-c]IMIDAZO[1,2-a]PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
03/05/2003EP1286998A1 Oxazolidinone derivatives with antibiotic activity
1 ... 5545 5546 5547 5548 5549 5550 5551 5552 5553 5554 5555 5556 5557 5558 5559 5560 5561 5562 5563 5564 5565 ... 7860